SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-04-001273
Filing Date
2004-04-01
Accepted
2004-04-01 15:48:50
Documents
5
Period of Report
2004-05-05
Effectiveness Date
2004-04-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT w95294d1def14a.htm DEF 14A 244367
3 GRAPHIC w95294d1guiphal1.gif GRAPHIC 7520
4 GRAPHIC w95294d1crsmith1.gif GRAPHIC 5238
5 GRAPHIC w95294d1ashrubs1.gif GRAPHIC 4288
6 GRAPHIC w95294d1w9529401.gif GRAPHIC 4768
  Complete submission text file 0000950133-04-001273.txt   268073
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23736 | Film No.: 04709556
SIC: 2834 Pharmaceutical Preparations